CN Patent

CN101815519B — 包含多巴胺受体配体的药物组合物和使用多巴胺受体配体的治疗方法

Assigned to Richter Gedeon Nyrt · Expires 2013-08-21 · 13y expired

What this patent protects

本发明涉及包含多巴胺受体配体和选择性5-羟色胺再摄取抑制剂的药物组合物和使用多巴胺受体配体和选择性5-羟色胺再摄取抑制剂的联合给药治疗例如精神分裂症、严重抑郁症和双相抑郁症等疾病的方法。本发明还涉及使用多巴胺受体配体治疗抑郁症的方法。

USPTO Abstract

本发明涉及包含多巴胺受体配体和选择性5-羟色胺再摄取抑制剂的药物组合物和使用多巴胺受体配体和选择性5-羟色胺再摄取抑制剂的联合给药治疗例如精神分裂症、严重抑郁症和双相抑郁症等疾病的方法。本发明还涉及使用多巴胺受体配体治疗抑郁症的方法。

Drugs covered by this patent

cariprazine-hydrochloride (CARIPRAZINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN101815519B
Jurisdiction: CN
Classification: —
Expires: 2013-08-21
Drug substance claim: No
Drug product claim: No
Assignee: Richter Gedeon Nyrt
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.